Rock Springs Capital

Location

Baltimore, United States

Total investments

154

Average round size

109M

Portfolio companies

122

Rounds per year

14.00

Lead investments

8

Follow on index

0.21

Exits

73

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologyDrug DiscoveryHealth CareHealth DiagnosticsMedical DeviceMedicalLife SciencePharmaceuticalTherapeuticsBiopharma

Summary

The main department of described VC is located in the Baltimore. The company was established in North America in United States.

For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular fund investment industries, there are Medical, Health Diagnostics. Among the most popular portfolio startups of the fund, we may highlight AveXis, Spark Therapeutics, Audentes Therapeutics. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

Opposing the other organizations, this Rock Springs Capital works on 49 percentage points more the average amount of lead investments. The higher amount of exits for fund were in 2015. Deals in the range of 50 - 100 millions dollars are the general things for fund. The typical startup value when the investment from Rock Springs Capital is 500 millions - 1 billion dollars. The real fund results show that this VC is 16 percentage points less often commits exit comparing to other companies. The fund is generally included in 7-12 deals every year. The top activity for fund was in 2015. Despite it in 2019 the fund had an activity.

Besides them, we counted 1 critical employee of this fund in our database.

The typical case for the fund is to invest in rounds with 8-9 participants. Despite the Rock Springs Capital, startups are often financed by OrbiMed, Sofinnova Investments, Bay City Capital. The meaningful sponsors for the fund in investment in the same round are Deerfield, Wellington Management, Vivo Capital. In the next rounds fund is usually obtained by New Enterprise Associates, Omega Funds, CARB-X.

Show more

Investor highlights

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
154
Lead investments
8
Exits
73
Rounds per year
14.00
Follow on index
0.21
Investments by industry
  • Biotechnology (137)
  • Health Care (82)
  • Medical (67)
  • Therapeutics (57)
  • Pharmaceutical (48)
  • Show 33 more
Investments by region
  • United States (127)
  • United Kingdom (9)
  • China (5)
  • Canada (3)
  • Singapore (2)
  • Show 7 more
Peak activity year
2021
Number of Unicorns
8
Number of Decacorns
8
Number of Minotaurs
15

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
12
Avg. valuation at time of investment
223M
Group Appearance index
1.00
Avg. company exit year
9
Avg. multiplicator
2.85
Strategy success index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Immuneering 05 Jan 2021 Biotechnology, Medical, Pharmaceutical Early Stage Venture 62M United States, Massachusetts, Cambridge
Treeline Biosciences 11 Oct 2022 Biotechnology, Health Care, Life Science Early Stage Venture 261M United States, Connecticut, Stamford

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.